제대혈 은행 서비스 시장 : 서비스, 보관, 최종사용자, 용도별 - 세계 예측(2025-2030년)

The Cord Blood Banking Services Market was valued at USD 32.91 billion in 2023, expected to reach USD 37.13 billion in 2024, and is projected to grow at a CAGR of 12.92%, to USD 77.09 billion by 2030.

Cord blood banking services refer to the collection, processing, and storage of blood from the umbilical cord and placenta post-delivery. This blood is rich in hematopoietic stem cells, which can differentiate into various blood cell types, offering therapeutic potential for treating cancers, blood disorders, and immune deficiencies. The necessity of cord blood banking arises from its role as a non-invasive alternative to bone marrow transplants and its potential in regenerative medicine. Its applications extend to both private banking for family use and public banking for research and broader community use. The end-use scope encompasses hospitals, research institutes, pharmaceutical biotech companies, and individuals seeking future health security for newborns.

In terms of market insights, key growth influencing factors include increased awareness regarding stem cell therapies, technological advancements in regenerative medicine, and favorable government initiatives promoting stem cell research. The rising incidence of genetic disorders also bolsters demand. However, challenges such as high costs of collection and storage, ethical concerns, and regulatory hurdles can impede growth. The market also faces issues with public awareness and education on the benefits and limitations of cord blood banking. Opportunities lie in expanding service accessibility and affordability through strategic partnerships and technological innovations in storage and preservation techniques, such as cryopreservation advancements.

Areas ripe for innovation and research include developing more efficient and cost-effective processing technologies, exploring the potential of cord blood-derived stem cells in novel therapeutic applications, and enhancing yield and viability of cells during storage. Moreover, establishing standardized protocols and enhancing public health campaigns can facilitate market penetration. The nature of the market is dynamic, characterized by rapid scientific advancements and an increasing emphasis on personalized medicine. Thus, companies should focus on research collaborations, regulatory navigation, and building robust public-private partnership models to leverage untapped demographic segments and secure a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cord Blood Banking Services Market

The Cord Blood Banking Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the population suffering from diseases arising from genetic mutation
  • Increasing the focus of government to set up public cord blood banking units
  • Growing awareness regarding the treatment line and increasing number of facilities
• Market Restraints
  • Adults needing a transplant require cord blood stem cells from multiple donors
  • Soaring high cost of the service and high probabilities of not finding suitable match
• Market Opportunities
  • Rising R&D activities in the healthcare sector and extensive development of the healthcare infrastructure
  • New advancements in cell expansion bring relevance to storing cord cells well beyond child-hood age
• Market Challenges
  • Regular updates in the standards and inspection by authorities

Porter's Five Forces: A Strategic Tool for Navigating the Cord Blood Banking Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cord Blood Banking Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cord Blood Banking Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cord Blood Banking Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cord Blood Banking Services Market

A detailed market share analysis in the Cord Blood Banking Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cord Blood Banking Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cord Blood Banking Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cord Blood Banking Services Market

A strategic analysis of the Cord Blood Banking Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cord Blood Banking Services Market, highlighting leading vendors and their innovative profiles. These include AlphaCord, LLC, Americord Registry LLC, Baby Gooroo, Inc., Celularity, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., CryoHoldco, Cryoviva Biotech Private Limited, Healthcord Cryogenics Corporation, MiracleCord Inc., PerkinElmer Inc., Progenics Cord Blood Cryobank, Reliance Life Sciences Private Limited, Smart Cells International Ltd., and StemCord Pte Ltd..

Market Segmentation & Coverage

This research report categorizes the Cord Blood Banking Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Services, market is studied across Processing and Storage.
• Based on Storage, market is studied across Private Cord Blood Bank and Public Cord Blood Bank.
• Based on End-User, market is studied across Hospitals, Research Institutes, and Specialty Clinics.
• Based on Application, market is studied across Blood Disorders, Bone Marrow Failure Syndrome, Cancer, Immuno-Deficiency Disorders, and Metabolic Disorders.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the population suffering from diseases arising from genetic mutation
    • 5.1.1.2. Increasing the focus of government to set up public cord blood banking units
    • 5.1.1.3. Growing awareness regarding the treatment line and increasing number of facilities
  • 5.1.2. Restraints
    • 5.1.2.1. Adults needing a transplant require cord blood stem cells from multiple donors
    • 5.1.2.2. Soaring high cost of the service and high probabilities of not finding suitable match
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities in the healthcare sector and extensive development of the healthcare infrastructure
    • 5.1.3.2. New advancements in cell expansion bring relevance to storing cord cells well beyond child-hood age
  • 5.1.4. Challenges
    • 5.1.4.1. Regular updates in the standards and inspection by authorities
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cord Blood Banking Services Market, by Services

• 6.1. Introduction
• 6.2. Processing
• 6.3. Storage

7. Cord Blood Banking Services Market, by Storage

• 7.1. Introduction
• 7.2. Private Cord Blood Bank
• 7.3. Public Cord Blood Bank

8. Cord Blood Banking Services Market, by End-User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Research Institutes
• 8.4. Specialty Clinics

9. Cord Blood Banking Services Market, by Application

• 9.1. Introduction
• 9.2. Blood Disorders
• 9.3. Bone Marrow Failure Syndrome
• 9.4. Cancer
• 9.5. Immuno-Deficiency Disorders
• 9.6. Metabolic Disorders

10. Americas Cord Blood Banking Services Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cord Blood Banking Services Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cord Blood Banking Services Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AlphaCord, LLC
• 2. Americord Registry LLC
• 3. Baby Gooroo, Inc.
• 4. Celularity, Inc.
• 5. Cordlife Group Limited
• 6. Cryo-Cell International, Inc.
• 7. CryoHoldco
• 8. Cryoviva Biotech Private Limited
• 9. Healthcord Cryogenics Corporation
• 10. MiracleCord Inc.
• 11. PerkinElmer Inc.
• 12. Progenics Cord Blood Cryobank
• 13. Reliance Life Sciences Private Limited
• 14. Smart Cells International Ltd.
• 15. StemCord Pte Ltd.